Drug Discovery and Development
1 / 2
Exosomes
Five Exosome Biotechs to Watch: July 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-01Jul 01, 2025
Nanoscale
Addressing Drug Delivery Challenges at the Nanoscale
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-25-NI-07Jun 16, 2025
Rare Disease
Rare Disease Biotech Announces ‘Hugely Significant’ Milestone with Selection of Candidate Drug
SynaptixBio
PR-06-25-NI-02Jun 10, 2025
Fundraising
Sano Women’s Health Raises Funds to Advance Phase 2 Clinical Trials for Novel RVVC Treatment
Sano Women's Health
PR-06-25-NI-01Jun 06, 2025
Protein Design
Reprogramming the Rules: How AI Is Transforming De Novo Protein Design in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-08Apr 15, 2025
First-in-Class Drugs
Breaking New Ground: 30 Years of First-in-Class Drug Innovation
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-27Apr 09, 2025
Microbiome
Innovating to Target the Microbiome for Human Health
Servatus
PAO-11-24-RTM-15Apr 08, 2025
Psychedelics
Unlocking the Potential of Psychedelics for Postpartum Depression
Greg Mayes, J.D.
Reunion Neuroscience
PAO-03-25-CL-05Mar 31, 2025
Drug Approvals
How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?
Pharma's Almanac
PAO-03-25-RT-01Mar 26, 2025
Advocacy
From Patients to Partners: The Rising Power of Advocacy in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-19Mar 13, 2025
Biomarkers
The Biomarker Revolution in Medicine and Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-16Mar 10, 2025
HTS
The High-Throughput Screening Transformation in Modern Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-12Mar 02, 2025
Accelerated Approval
30 Years of Accelerated Approvals: Fast-Tracking Innovation in Drug Development
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-07Mar 02, 2025
Structural Biology
The Disruptive Impact of Structural Biology on Biopharmaceutical Innovation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-13Mar 02, 2025
Real-World Evidence
Overcoming Challenges and Unlocking the Potential of Real-World Evidence
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-09Mar 02, 2025
Cannabinoids
Unlocking New Frontiers with Cannabinoid and Psychedelic Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-04Mar 02, 2025
Biosimilars
Biosimilars Through the Years: Transforming Access and Cost in Biologics
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-01Mar 02, 2025
Small Biotechs
Five Small Biotechs to Watch: March 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-06Feb 28, 2025
Radioconjugates
Rising Interest in Radioconjugate Therapies
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-02-25-NI-05Feb 25, 2025
Biotechs
Five Small Biotechs to Watch: February 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-01Feb 03, 2025
1 / 2